查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1579978

癌症影像系統市場：按產品、成像技術、影像模式、適應症和最終用戶 - 2025-2030 年全球預測

Cancer Imaging System Market by Product (Consumables & Accessories, Imaging Systems, Software), Imaging Technology (Computed Tomography, Magnetic Resonance Imaging, Molecular Imaging), Mode of Imaging, Indication, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年癌症影像系統市值為184.3億美元，預計到2024年將達到201.6億美元，複合年成長率為9.57%，預計到2030年將達到349.6億美元。

癌症影像系統市場包括診斷、分期和監測癌症所必需的各種技術，例如 MRI、 電腦斷層掃描、PET 掃描、超音波和 X 光成像。全球癌症發病率上升推動了這個市場的需求，這需要先進的診斷工具來改善患者的治療效果並促進精準醫療。市場的應用遍及各地，包括醫院、診所、診斷實驗室和研究機構，主要由腫瘤科醫生、放射科醫生和醫療專業人員用來規劃治療。成像技術的進步推動了成長，包括整合人工智慧以增強影像分析，從而提高診斷準確性和效率。最新的潛在商機在於為醫療基礎設施仍不發達的新興經濟體開發可攜式診斷影像設備和個人化應用。然而，法律規範、影像處理系統的高成本以及對輻射暴露的擔憂構成了重大挑戰。然而，這些問題可以透過投資於最大限度地降低輻射風險並提高成本效益的研究來緩解。該市場受到政府醫療保健計劃和癌症治療資金、高科技公司與醫療保健提供者之間的策略聯盟以及消費者對高效醫療保健解決方案日益成長的偏好的顯著影響。創新策略包括增強軟體以實現更好的影像處理、利用機器學習進行預測分析以及為農村地區開發負擔得起的診斷成像設備。隨著市場因技術進步而蓬勃發展，持續的研發和策略聯盟提供了競爭優勢。識別新興市場中未滿足的需求並專注於以患者為中心的影像解決方案可以提供重大的成長機會。從本質上講，癌症成像系統市場是動態的，創新的機會可以克服其局限性，特別是透過最尖端科技的策略整合和新興市場的擴張。

主要市場統計
基準年[2023] 184.3億美元
預測年份 [2024] 201.6億美元
預測年份 [2030] 349.6億美元
複合年成長率（%） 9.57%

市場動態：快速發展的癌症成像系統市場的關鍵市場洞察

供需的動態交互作用正在改變癌症成像系統市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界老年人口的增加
    • 全球癌症盛行率上升
    • 政府對癌症治療的支持措施
  • 市場限制因素
    • 癌症影像系統高成本
  • 市場機會
    • 持續合作整合先進成像技術
    • 增加對先進成像技術研發活動的投資
  • 市場挑戰
    • 影像資料管理和互通性問題

波特五力：駕馭癌症影像系統市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解癌症影像系統市場的外部影響

外部宏觀環境因素在塑造癌症成像系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解癌症影像系統市場的競爭格局

對癌症成像系統市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣癌症影像系統市場供應商績效評估

FPNV 定位矩陣是評估癌症影像系統市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定癌症成像系統市場成功之路的策略分析和建議

對於旨在加強其在全球市場的影響力的公司來說，癌症成像系統市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球人口老化仍在持續
      • 全球癌症發生率正在上升
      • 政府對癌症治療的支持措施
    • 抑制因素
      • 癌症影像系統高成本
    • 機會
      • 持續合作整合先進成像技術
      • 增加對先進影像技術研發活動的投資
    • 任務
      • 影像資料管理和互通性問題
  • 市場區隔分析
    • 產品：醫院影像系統的使用激增，以滿足複雜的影像需求
    • 最終用戶：癌症研究機構對先進診斷影像系統的需求不斷增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章癌症影像系統市場：依產品

  • 耗材及配件
  • 影像系統
    • 可攜式成像設備
    • 獨立影像擷取設備
  • 軟體
    • 影像分析軟體
    • 輻射資訊系統

第7章癌症影像系統市場影像技術

  • 電腦斷層掃描
  • 磁振造影
  • 分子影像
  • 光學成像
  • 正子斷層掃描
  • 超音波影像診斷
  • X 光影像

第8章依影像模式分類的癌症影像系統市場

  • 2D成像
  • 3D成像
  • 4D成像

第9章癌症影像系統市場（按適應症）

  • 腦腫瘤
  • 乳癌
  • 子宮頸癌
  • 大腸直腸癌
  • 肝癌
  • 肺癌
  • 攝護腺癌

第 10 章癌症影像系統市場：依最終使用者分類

  • 門診手術中心
  • 癌症研究組織
  • 影像診斷中心
  • 醫院

第11章美洲癌症影像系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區癌症影像系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的癌症影像系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • GE Healthcare 在 ESTRO 2024 會議上推出人工智慧驅動的個人化腫瘤解決方案
    • GE Healthcare 的 MIM 軟體與 Elekta 合作，增強放射治療並改善病患治療效果。
    • GE Healthcare 透過收購 MIM Software 擴展癌症成像能力
  • 戰略分析和建議

公司名單

  • Agfa-Gevaert NV
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Carestream Health
  • Curium
  • Elekta AB
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Hologic, Inc.
  • iCAD, Inc.
  • Imaging Endpoints
  • Koning Corporation
  • Medtronic PLC
  • PerkinElmer, Inc.
  • Philips Healthcare
  • Planmed Oy
  • RadNet, Inc.
  • Samsung Medison
  • Siemens Healthineers
  • Spectrum Dynamics Medical
  • Thermo Fisher Scientific Inc.
  • United Imaging Healthcare Co., Ltd.
  • Varian Medical Systems
  • ViewRay, Inc.
  • Ziehm Imaging GmbH
Product Code: MRR-3204321AF6C5

The Cancer Imaging System Market was valued at USD 18.43 billion in 2023, expected to reach USD 20.16 billion in 2024, and is projected to grow at a CAGR of 9.57%, to USD 34.96 billion by 2030.

The cancer imaging system market covers a range of technologies, including MRI, CT scans, PET scans, ultrasound, and X-ray imaging, each essential in diagnosing, staging, and monitoring cancer. This market's necessity stems from the rising global cancer incidence that demands advanced diagnostic tools to improve patient outcomes and facilitate precision medicine. It finds application across hospitals, clinics, diagnostic labs, and research institutions, primarily used by oncologists, radiologists, and medical professionals to guide treatment plans. Growth is spurred by advancements in imaging technology, such as AI integration for enhanced image analysis, which accelerates diagnostic accuracy and efficiency. Latest potential opportunities lie in developing portable imaging devices and personalized applications that cater to emerging economies where healthcare infrastructure is still developing. Meanwhile, regulatory frameworks, high costs of imaging systems, and radiation exposure concerns pose significant challenges. However, investing in research that minimizes radiation risks and enhances cost-effectiveness can mitigate these issues. The market is considerably influenced by governmental healthcare initiatives and funding towards cancer treatment, strategic collaborations between tech companies and healthcare providers, and an increasing consumer preference for efficient healthcare solutions. Innovative strategies include enhancing software for better image processing, utilizing machine learning for predictive analytics, and creating more affordable imaging equipment for rural areas. As the market thrives on technological progression, continuous R&D and strategic alliances can offer competitive advantages. Identifying unmet needs in emerging markets and focusing on patient-centric imaging solutions can provide substantial growth opportunities. In essence, the cancer imaging systems market is dynamic, with opportunities for innovation overshadowing its limitations, particularly through the strategic integration of cutting-edge technologies and expanding reach across developing regions.

KEY MARKET STATISTICS
Base Year [2023] USD 18.43 billion
Estimated Year [2024] USD 20.16 billion
Forecast Year [2030] USD 34.96 billion
CAGR (%) 9.57%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cancer Imaging System Market

The Cancer Imaging System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population globally
    • Rising prevalence of cancer globally
    • Supportive government initiatives for cancer treatments
  • Market Restraints
    • High costs of cancer imaging systems
  • Market Opportunities
    • Ongoing collaborative activities for integrating advanced imaging technologies
    • Rising investments in R&D activities for advanced imaging technologies
  • Market Challenges
    • Data management and interoperability issues of imaging data

Porter's Five Forces: A Strategic Tool for Navigating the Cancer Imaging System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cancer Imaging System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cancer Imaging System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cancer Imaging System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cancer Imaging System Market

A detailed market share analysis in the Cancer Imaging System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cancer Imaging System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cancer Imaging System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cancer Imaging System Market

A strategic analysis of the Cancer Imaging System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cancer Imaging System Market, highlighting leading vendors and their innovative profiles. These include Agfa-Gevaert N.V., Bruker Corporation, Canon Medical Systems Corporation, Carestream Health, Curium, Elekta AB, Esaote S.p.A., Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd., Hologic, Inc., iCAD, Inc., Imaging Endpoints, Koning Corporation, Medtronic PLC, PerkinElmer, Inc., Philips Healthcare, Planmed Oy, RadNet, Inc., Samsung Medison, Siemens Healthineers, Spectrum Dynamics Medical, Thermo Fisher Scientific Inc., United Imaging Healthcare Co., Ltd., Varian Medical Systems, ViewRay, Inc., and Ziehm Imaging GmbH.

Market Segmentation & Coverage

This research report categorizes the Cancer Imaging System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables & Accessories, Imaging Systems, and Software. The Imaging Systems is further studied across Portable Imaging Devices and Stand-alone Imaging Equipment. The Software is further studied across Imaging Analysis Software and Radiology Information Systems.
  • Based on Imaging Technology, market is studied across Computed Tomography, Magnetic Resonance Imaging, Molecular Imaging, Optical Imaging, Positron Emission Tomography, Ultrasound Imaging, and X-Ray Imaging.
  • Based on Mode of Imaging, market is studied across 2D Imaging, 3D Imaging, and 4D Imaging.
  • Based on Indication, market is studied across Brain Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, and Prostate Cancer.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Imaging Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population globally
      • 5.1.1.2. Rising prevalence of cancer globally
      • 5.1.1.3. Supportive government initiatives for cancer treatments
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of cancer imaging systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing collaborative activities for integrating advanced imaging technologies
      • 5.1.3.2. Rising investments in R&D activities for advanced imaging technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Data management and interoperability issues of imaging data
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product : Proliferating use of imaging systems in hospitals for intricate imaging needs
    • 5.2.2. End-User : Rising demand for advanced imaging systems cancer research institutes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cancer Imaging System Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables & Accessories
  • 6.3. Imaging Systems
    • 6.3.1. Portable Imaging Devices
    • 6.3.2. Stand-alone Imaging Equipment
  • 6.4. Software
    • 6.4.1. Imaging Analysis Software
    • 6.4.2. Radiology Information Systems

7. Cancer Imaging System Market, by Imaging Technology

  • 7.1. Introduction
  • 7.2. Computed Tomography
  • 7.3. Magnetic Resonance Imaging
  • 7.4. Molecular Imaging
  • 7.5. Optical Imaging
  • 7.6. Positron Emission Tomography
  • 7.7. Ultrasound Imaging
  • 7.8. X-Ray Imaging

8. Cancer Imaging System Market, by Mode of Imaging

  • 8.1. Introduction
  • 8.2. 2D Imaging
  • 8.3. 3D Imaging
  • 8.4. 4D Imaging

9. Cancer Imaging System Market, by Indication

  • 9.1. Introduction
  • 9.2. Brain Cancer
  • 9.3. Breast Cancer
  • 9.4. Cervical Cancer
  • 9.5. Colorectal Cancer
  • 9.6. Liver Cancer
  • 9.7. Lung Cancer
  • 9.8. Prostate Cancer

10. Cancer Imaging System Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Cancer Research Institutes
  • 10.4. Diagnostic Imaging Centers
  • 10.5. Hospitals

11. Americas Cancer Imaging System Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Cancer Imaging System Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Cancer Imaging System Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. GE Healthcare unveils AI-enhanced personalized oncology solutions at ESTRO 2024 Congress
    • 14.3.2. GE Healthcare's MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes
    • 14.3.3. GE Healthcare expands cancer imaging capabilities with acquisition of MIM Software
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agfa-Gevaert N.V.
  • 2. Bruker Corporation
  • 3. Canon Medical Systems Corporation
  • 4. Carestream Health
  • 5. Curium
  • 6. Elekta AB
  • 7. Esaote S.p.A.
  • 8. Fujifilm Holdings Corporation
  • 9. GE Healthcare
  • 10. Hitachi Ltd.
  • 11. Hologic, Inc.
  • 12. iCAD, Inc.
  • 13. Imaging Endpoints
  • 14. Koning Corporation
  • 15. Medtronic PLC
  • 16. PerkinElmer, Inc.
  • 17. Philips Healthcare
  • 18. Planmed Oy
  • 19. RadNet, Inc.
  • 20. Samsung Medison
  • 21. Siemens Healthineers
  • 22. Spectrum Dynamics Medical
  • 23. Thermo Fisher Scientific Inc.
  • 24. United Imaging Healthcare Co., Ltd.
  • 25. Varian Medical Systems
  • 26. ViewRay, Inc.
  • 27. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. CANCER IMAGING SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. CANCER IMAGING SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CANCER IMAGING SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CANCER IMAGING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CANCER IMAGING SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CANCER IMAGING SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PORTABLE IMAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY STAND-ALONE IMAGING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY RADIOLOGY INFORMATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY 4D IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CANCER IMAGING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES CANCER IMAGING SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 318. TURKEY CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY MODE OF IMAGING, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 332. UNITED KINGDOM CANCER IMAGING SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 333. CANCER IMAGING SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 334. CANCER IMAGING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023